BioSpace News Archive

Brand Institute is proud to announce its work with Osmotica Pharmaceuticals in developing the brand name RELEXXII®.

MindMaze, a global pioneer in the development of neurotechnology, today confirms a new partnership with Alfa Romeo F1 Team ORLEN.

Innoviva, Inc. (Nasdaq: INVA) (“Innoviva”), a diversified holding company with a portfolio of royalties, today announced the successful completion of its acquisition of Entasis Therapeutics Holdings Inc.

Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (the “Company” or “Inspira Technologies”) introduces today the “Liby™" System, an advanced form of life support better known by the medical industry as extracorporeal membrane oxygenation (ECMO), used to treat patients with life-threatening heart and lung failure.

Codiak BioSciences, Inc. (Nasdaq: CDAK), a clinical-stage biopharmaceutical company pioneering the development of exosome-based therapeutics as a new class of medicines, today announced that management will be attending the William Blair Biotech Focus Conference 2022 in New York City.

Joan & Sanford I. Weill Medical College of Cornell University (“Weill Cornell”) located in New York, NY has been awarded $240,000 over a 2-year period from the Thymic Carcinoma Center headquartered in Olathe, Kansas for the development of new models of Thymic Epithelial Tumors (TET’s).

Today, Pfizer Canada and Rethink Breast Cancer are excited to announce the recipients of the nearly $280,000 in grants for the implementation of innovative strategies aimed at measurably improving the quality of care for people living with metastatic breast cancer (MBC).

Nanomerics Ltd ., a private speciality pharmaceutical company, today announced that Nanomerics’ Chief Scientific Officer would be giving a plenary lecture at the Controlled Release Society Annual Meeting and Expo on Wednesday 13th  July 2022. 

Athos Therapeutics, Inc. (“Athos”), a late-stage preclinical biotech company using artificial intelligence to develop small molecule therapeutics for immune-mediated diseases and cancer, announced today a comprehensive Master Research Agreement for a collaborative project on Inflammatory Bowel Disease (IBD) with Lahey Hospital & Medical Center (“Lahey”).

Anodyne Pain & Wellness Solutions announced today its acquisition of Arizona-based Integrated Pain Consultants (IPC), a pain management practice specializing in groundbreaking pain intervention treatments for acute and chronic pain.